Illumina has announced the launch of the VeriSeq™ NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT), including CE-IVD marked library ...
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced that it has declared conformity with the requirements of the IVD Directive and has applied the CE mark to an expanded VeriSeq™ ...
Next-generation Sequencing-based CE-IVD Solution Provides Accurate, Reliable, Fast and Scalable End-to-end Genome-wide Noninvasive Prenatal Testing Illumina's VeriSeq NIPT Solution v2 (Photo: Business ...
Global leader in the field of DNA sequencing and array-based technologies, Illumina, Inc. ILMN recently announced the launch of a solution pertaining to its noninvasive prenatal testing (NIPT) range ...
Hamilton Robotics continues to strengthen their ongoing partnership with Illumina, Inc. through the collaborative development of the VeriSeq™ NIPT Solution for high-throughput noninvasive prenatal ...
Illumina is set to start selling a scaled-up version of its VeriSeq noninvasive prenatal testing (NIPT) analysis software to clinical labs in the European Union. The latest iteration handles batches ...
MELBOURNE, Australia--(BUSINESS WIRE)--Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of ...
Illumina, Inc. (NASDAQ: ILMN) today announced that it has declared conformity with the requirements of the IVD Directive and has applied the CE mark to an expanded VeriSeq™ NIPT Analysis Software for ...
Illumina, Inc., the global leader in DNA sequencing and array-based technologies, and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations (ASEAN) leaders in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results